MIRA INFORM REPORT

 

 

Report Date :           

19.03.2011

 

IDENTIFICATION DETAILS

 

Name :

BARRETT HODGSON PAKISTAN (PRIVATE) LTD

 

 

Registered Office :

F-423, S.I.T.E., Karachi

 

 

Country :

Pakistan

 

 

Year of Establishment :

1992

 

 

Com. Reg. No.:

0028289

 

 

Legal Form :

Private Limited Company

 

 

Line of Business :

Manufacture & Marketing of Pharmaceutical Products

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 31, 2010

 

Country Name

Previous Rating

                   (30.09.2010)                  

Current Rating

(31.12.2010)

Pakistan

b2

b2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

                       

Business Name

 

BARRETT HODGSON PAKISTAN (PRIVATE) LTD

 

 

Full Address       

 

Registered Address & Factory

F-423, S.I.T.E., Karachi, Pakistan

                       

Tel #

92 (21) 32570651 - 57 (7 Lines)

Fax #

92 (21) 32568827, 32570650

 

 

Short Description Of Business

 

a.

Nature of Business        

Manufacture & Marketing of Pharmaceutical Products

b.

Year Established

1992

c.

Registration #

0028289

 

 

Branches

 

Address

1-A, Shahid Plaza, Jinnah Avenue, Blue Area, Islamabad, Pakistan

Tel #

92 (51) 2277098, 2270275

Fax #

92 (51) 2270277

           

Address

175, Gen. Sarfraz Khan Road, Shadman-II, Lahore, Pakistan

Tel #

92 (42) 37562711, 37562705

Fax #

92 (42) 37582854

 

 

Auditors

 

M/s A.F. Ferguson & Company

(Chartered Accountants)

State Life Building, 1-C, Off: I.I. Chundrigar Road, Karachi, Pakistan

 

 

 

Legal Status

 

Subject Company was established as a Private Limited Company in 1992

 

 

Authorized Capital

Rs. 250,000,000/- divided into 2,500,000 shares of Rs. 100/- each

Issued & Paid up Capital

Rs. 136,570,000/- divided into 1,365,700 shares of Rs. 100/- each

 

 

Details of Directors

 

Names

Nationality

Address

Designation

Dr. Iram Afaq

 

 

 

Mr. Tariq Amin

 

 

 

Dr. M.S. Habib

 

 

 

Mr. Shahid Mansoor

 

 

 

Dr. Hasan Tharani

 

 

Mr. S. Shakeel Ahmed

Pakistani

 

 

 

Pakistani

 

 

 

Pakistani

 

 

 

Pakistani

 

 

 

Pakistani

 

 

Pakistani

166, Khayaban-e-Shahbaz, Phase VI, DHA, Karachi

 

House No. 34/II, Khayaban-e-Badar, Phase-V, DHA, Karachi

 

166, Khayaban-e-Shahbaz, Phase VI, DHA, Karachi

 

House No. C-55, Block 9, Gulshan-e-Iqbal, Karachi

 

B-112, Block-10, Gulshan-e-Iqbal, Karachi

 

D/17, Askari-IV, Apartment, Rashid Minhas Road, Karachi

Chief Executive

 

 

 

Director

 

 

 

Director

 

 

 

Director

 

 

 

Director

 

 

Director

 

 

Shareholders                

 

Names

No. of Shares

Barrett Hodgson Limited, U.K.

 

Dr. M.S. Habib

 

Mr. Benyamin Naeem Habib

 

Dr. Iram Afaq

1,207,279

 

57,599

 

100,821

 

1

 

 

Associates                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

 

A.         Subsidiary

 

                        None                                            

           

B.         Associated Companies

 

(1) Lahore Medical Instruments (Pvt) Limited, Pakistan.

 

 

 

10. Products

 

Manufacture & marketing of different pharmaceutical class like Anti Biotic, Anti Malarials, Anti-Rheumatic, Antihistamine, Narcotic Analgesic, Non Steroidal Respiratory Anti Inflamatory, Quinolones, Vitamins, Phenothiazine, Hypolipidaemics, Muscle Relaxant, Amoebicide, Calcium-Antagonist, Cardio Selective Beta Blocker with their brand names of ACICON, BAMBEC, BAYHEP, BETALOC ZOK, BETAXEN, BINADEX, BRICANYL, CEFAMEZIN, CEFCOM, CEFIX, CEFIZOX, CEFNIR, CEFSPAN, CIPOCAINE, CIPOTIC, DOMEL, DYNAQUIN, ERADEP, EXOCIN, FEBROL, FLUCOL, GENTICYN, GIXER, INOCEF, INOQUIN, JECTOFER, LEVAQUIN, MOBIKARE GEL, MST CONTINUS, MYLAXON, OCUFEN, PENGLOBE, PERSCH, PLENDIL, POLYFER, PRED FORTE, PULMICORT, QUINTEC, RECOL, ROMICEF, SARTAN, WINTAX, XYLOAID, XYLOCAINE, ADRENALINE  

 

Number of Employees

 

335      

 

 

Annual Production Volume

 

The capacity and production of the company’s plant is indeterminable as it is multi-product and involves varying processes of manufacture

 

 

Annual Sales Volume

 

Year

In Pak Rupees

2009

520,000,000/- (Estimated)

 

 

 

Agencies

(Foreign)

 

·         ASTRAZENECA, U.K.     

·         ASTELLAS DEUTSCHLAND GMBH, GERMANY.

·         MIKA PHARMA GMBH, GERMANY.

·         ALLERGAN, U.S.A.

·         ZHEJIANG JINGXIN PHARMACEUTICAL IMPORT & EXPORT, CHINA.

 

 

Distributors

 

More than 100 Distributors in all over Pakistan

 

 

Exporting Countries

 

Mainly to Asian, Middle East and European Countries

 

 

Bankers

 

·         Faysal Bank Limited, Pakistan.

·         Habib Bank Limited, Pakistan.

·         Habib Metropolitan Bank Limited, Pakistan.

·         Standard Chartered Bank, Pakistan.

·         Saudi Pak Commercial Bank Limited, Pakistan.

·         ABN AMRO Bank, Pakistan.

 

 

Memberships

 

·         Pakistan Pharmaceutical Manufacturers Associations.(PPMA)

·         Karachi Chamber of Commerce & Industry.(KCCI)

 

 

Foreign Exchange Rates

 

Currency

 

Unit

Pakistani Rupee

US Dollar

1

           Rs. 85.30

UK Pound

1

           Rs. 137.39

Euro

1

           Rs. 119.36

 

Comments

 

Subject Company was established in 1992 and is engaged in manufacturing & marketing of Pharmaceutical Products. Market reputation is extremely good. Directors are reported as resourceful and experienced professionals. Trade relations are reported as fair. The Company can be considered for normal business dealings at usual trade terms and conditions.

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.45.09

UK Pound

1

Rs.72.82

Euro

1

Rs.63.43

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.